Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma:The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience

MLA

Alexandra Albertsson-Lindblad, et al. Pre-Treatment Health-Related Quality of Life Parameters Have Prognostic Impact in Patients >65 Years with Newly Diagnosed Mantle Cell Lymphoma:The Nordic Lymphoma Group MCL4 (LENA-BERIT) Experience. Jan. 2022. EBSCOhost, https://doi.org/10.1002/hon.2940.

APA

Alexandra Albertsson-Lindblad, Christian Winther Eskelund, Åsa Lindberg, Arne Kolstad, Christian H. Geisler, Kirsten Grønbæk, Riikka Räty, Anna Laurell, & Mats Jerkeman. (2022). Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma:The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience. https://doi.org/10.1002/hon.2940

Chicago

Alexandra Albertsson-Lindblad, Christian Winther Eskelund, Åsa Lindberg, Arne Kolstad, Christian H. Geisler, Kirsten Grønbæk, Riikka Räty, Anna Laurell, and Mats Jerkeman. 2022. “Pre-Treatment Health-Related Quality of Life Parameters Have Prognostic Impact in Patients >65 Years with Newly Diagnosed Mantle Cell Lymphoma:The Nordic Lymphoma Group MCL4 (LENA-BERIT) Experience,” January. doi:10.1002/hon.2940.